Antabio Wins $2.8 Million Public-Private Partnership Grant to Keep Developing Drug-Resistant Infection Therapy
News
A U.S. government-backed initiative against drug-resistant bacteria has awarded Antabio $2.8 million to continue developing treatments for Pseudomonas, the most common infection in cystic fibrosis (CF). The grant came from a ... Read more